Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024

Date: March 29, 2019
Pages: 147
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: UB0B237A5C0EN
Leaflet:

Download PDF Leaflet

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024
“Urinalysis market to register a CAGR of 7.6% from 2019 to 2024”

The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024. The growth of the market is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market.

“Consumables accounted for a significant share of the market in 2019”

By product, the urinalysis market is segmented into consumables and instruments. The consumables segment includes pregnancy and fertility kits, dipsticks, reagents, and disposables, while the instruments segment includes automated urine analyzers, semi-automated urine analyzers, and point-of-care urine analyzers. The consumables segment dominated the market and is the fastest growing segment due to rising incidence of urinary tract infections and kidney diseases which creates the demand for regular urine checkups.

“Pregnancy and fertility tests segment accounted for the largest share of the urinalysis market in 2019”

The urinalysis market, by test type, is segmented into biochemical urinalysis, sediment urinalysis, and pregnancy & fertility tests. The pregnancy & fertility tests segment is estimated to account for the largest share of the urinalysis market in 2019 while the sediment urinalysis segment is estimated to witness the highest growth rate during the forecast period. The rising incidence of UTIs and kidney diseases and the shift towards automation are the major factors driving the growth of this segment.

“Disease screening segment accounted for the largest share of the urinalysis market in 2019”

On the basis of application, the urinalysis market is segmented into disease screening and pregnancy & fertility. In the disease screening segment, UTIs have the largest market share. Urine analysis has become a part of the general check-up in many countries and is used as a preliminary technique for screening for UTIs and other kidney diseases. This is followed by high throughput technique for diagnosing the diseases.

“Hospitals and clinics segment accounted for the largest share of the urinalysis market in 2019”

On the basis of end user, the urinalysis market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, and research laboratories & institutes. Of all these end-user segments, hospitals & clinics accounted for the largest share of the urinalysis market in 2019. The large share of this segment can be attributed to factors such as the rapidly growing aging population, the increasing global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals among others.

“North America dominated the urinalysis market in 2019”

North America, which includes the US, & Canada, accounted for the largest share of the urinalysis market. The growth in this market is primarily driven by the increasing prevalence of UTIs and kidney diseases, rising geriatric population, favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and availability of technologically advanced urinalysis instruments in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
  • By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia (25%), and RoW (16%)
The major players operating in this market are Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Bio-Rad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US) and URIT Medical Electronic Ltd. (China). Product launches, partnerships and acquisitions are the key growth strategies followed by most players in this market.

Research Coverage

This report studies the urinalysis market based on product, test type, application end user and region. The report also analyzes factors (such as drivers, restraints and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total urinalysis market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on urinalysis offered by the top 13 players in the urinalysis market. The report analyzes the urinalysis market by type, application, and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various urinalysis across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinalysis market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the urinalysis market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
  1.2.1 MARKETS COVERED
  1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 SECONDARY DATA
  2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
  2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
  2.3.1 BOTTOM-UP APPROACH
  2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 URINALYSIS: MARKET OVERVIEW
4.2 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT (2019)
4.3 GEOGRAPHICAL SNAPSHOT OF THE URINALYSIS MARKET

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 DRIVERS
    5.2.1.1 Growing global prevalence of kidney diseases and urinary tract infections
    5.2.1.2 Shift towards automation in sediment analysis
    5.2.1.3 Increasing adoption of point-of-care urinalysis
  5.2.2 OPPORTUNITIES
    5.2.2.1 Integrated systems for urinalysis
    5.2.2.2 Emerging economies
  5.2.3 CHALLENGES
    5.2.3.1 High cost of automated analyzers affecting market penetration in emerging economies

6 URINALYSIS MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 CONSUMABLES
  6.2.1 PREGNANCY & FERTILITY KITS
    6.2.1.1 Need for rapid pregnancy testing to drive market growth
  6.2.2 DIPSTICKS
    6.2.2.1 Dipsticks are used regularly due to their low cost and ease of use
  6.2.3 DISPOSABLES
    6.2.3.1 Wide usage of urine collection cups will drive the market for disposables
  6.2.4 REAGENTS
    6.2.4.1 Increasing use of controls and calibrators to drive market growth
6.3 INSTRUMENTS
  6.3.1 AUTOMATED URINE ANALYZERS
    6.3.1.1 Biochemical urine analyzers
      6.3.1.1.1 Increasing incidence of kidney diseases and urinary tract infections will increase the demand for automated biochemical analyzers
    6.3.1.2 Sediment urine analyzers
      6.3.1.2.1 Microscopy analyzers
        6.3.1.2.1.1 Increased adoption of automated microscopy analyzers to drive market growth
      6.3.1.2.2 Flow cytometry analyzers
        6.3.1.2.2.1 Accuracy and sensitivity of flow cytometry technique to drive the adoption of these analyzers
    6.3.1.3 Integrated urine analyzers
      6.3.1.3.1 Higher workload in hospitals and laboratories to drive the adoption of integrated systems
  6.3.2 SEMI-AUTOMATED URINE ANALYZERS
    6.3.2.1 Semi-automated urine analyzers are used extensively due to their low cost and ease of use
  6.3.3 POINT-OF-CARE URINE ANALYZERS
    6.3.3.1 Need for rapid testing to drive the demand for PoC devices

7 URINALYSIS MARKET, BY TEST TYPE

7.1 INTRODUCTION
7.2 PREGNANCY & FERTILITY TESTS
  7.2.1 RISING INCIDENCE OF ACCIDENTAL PREGNANCIES TO DRIVE THE GROWTH OF THIS SEGMENT
7.3 BIOCHEMICAL URINALYSIS
  7.3.1 LABORATORY TESTS
    7.3.1.1 Increasing incidence of urinary tract infections and kidney diseases to drive the growth of this segment
  7.3.2 POINT-OF-CARE TESTS
    7.3.2.1 Ease and convenience of poc testing to drive the growth of this segment during the forecast period
7.4 SEDIMENT URINALYSIS
  7.4.1 INCREASING ADOPTION OF AUTOMATED ANALYZERS TO DRIVE THE GROWTH OF THIS SEGMENT

8 URINALYSIS MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 DISEASE SCREENING
  8.2.1 URINARY TRACT INFECTIONS
    8.2.1.1 Increasing prevalence of UTIs to drive growth in the urinalysis market for disease screening
  8.2.2 KIDNEY DISEASES
    8.2.2.1 Rapidly growing global geriatric population and the subsequent increase in the prevalence of kidney diseases to drive market growth
  8.2.3 DIABETES
    8.2.3.1 Development of advanced analytical tools for diabetes will drive market growth
  8.2.4 LIVER DISEASES
    8.2.4.1 High prevalence of liver diseases will increase the demand for urinalysis
  8.2.5 OTHER DISEASE SCREENING APPLICATIONS
8.3 PREGNANCY & FERTILITY
  8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY & FERTILITY TO DRIVE GROWTH IN THE URINALYSIS MARKET

9 URINALYSIS MARKET, BY END USER

9.1 INTRODUCTION
9.2 HOSPITALS & CLINICS
  9.2.1 INCREASE IN HOSPITALIZATIONS FOR URINARY DISEASES TO DRIVE GROWTH IN THIS END-USER SEGMENT
9.3 DIAGNOSTIC LABORATORIES
  9.3.1 LARGE NUMBER OF DIAGNOSTIC LABORATORIES CARRYING OUT TESTS GLOBALLY TO DRIVE MARKET GROWTH
9.4 HOME CARE SETTINGS
  9.4.1 WIDESPREAD USE OF PREGNANCY KITS IN HOME CARE SETTINGS TO DRIVE MARKET GROWTH
9.5 RESEARCH LABORATORIES & INSTITUTES
  9.5.1 RESEARCH IN DEVELOPING NEW URINALYSIS KITS FOR DISEASE DIAGNOSIS WILL DRIVE MARKET GROWTH

10 URINALYSIS MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
  10.2.1 US
    10.2.1.1 US dominates the North American urinalysis market
  10.2.2 CANADA
    10.2.2.1 Increasing awareness about UTIs will drive market growth in Canada
10.3 EUROPE
  10.3.1 GERMANY
    10.3.1.1 Germany dominates the European urinalysis market
  10.3.2 UK
    10.3.2.1 UK to register the highest growth in the European market during the forecast period
  10.3.3 FRANCE
    10.3.3.1 Favorable demographics will support the adoption of urinalysis equipment in France
  10.3.4 ITALY
    10.3.4.1 Large geriatric population to drive the growth of the urinalysis market in Italy
  10.3.5 SPAIN
    10.3.5.1 Prevalence of CKD in Spain to drive the demand for urinalysis
  10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
  10.4.1 CHINA
    10.4.1.1 China accounts for the largest share of the APAC market
  10.4.2 JAPAN
    10.4.2.1 Well-developed healthcare system and universal healthcare reimbursement policy will ensure steady market growth
  10.4.3 INDIA
    10.4.3.1 Increasing incidence of CKD is driving market growth
  10.4.4 REST OF APAC
10.5 REST OF THE WORLD

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 MARKET RANKING ANALYSIS, 2018
11.3 KEY STRATEGIES
  11.3.1 PRODUCT LAUNCHES, 2016–2018
  11.3.2 EXPANSIONS, 2016–2018
  11.3.3 PARTNERSHIPS, 2016–2018
11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
  11.4.1 VENDOR INCLUSION CRITERIA
  11.4.2 VISIONARY LEADERS
  11.4.3 INNOVATORS
  11.4.4 DYNAMIC DIFFERENTIATORS
  11.4.5 EMERGING COMPANIES
11.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2018)
  11.5.1 PROGRESSIVE COMPANIES
  11.5.2 STARTING BLOCKS
  11.5.3 RESPONSIVE COMPANIES
  11.5.4 DYNAMIC COMPANIES

12 COMPANY PROFILES

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 CARDINAL HEALTH, INC.
12.2 ALERE, INC. (A PART OF ABBOTT LABORATORIES)
12.3 SIEMENS HEALTHINEERS
12.4 ROCHE DIAGNOSTICS
12.5 BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORPORATION)
12.6 SYSMEX CORPORATION
12.7 QUIDEL CORPORATION
12.8 BIO-RAD LABORATORIES, INC.
12.9 ARKRAY, INC.
12.10 ACON LABORATORIES, INC.
12.11 77 ELEKTRONIKA KFT
12.12 URIT MEDICAL ELECTRONIC GROUP CO., LTD.
12.13 DIRUI INDUSTRIAL CO., LTD.
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX

13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 URINALYSIS MARKET: BOTTOM-UP APPROACH
FIGURE 4 URINALYSIS MARKET: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 URINALYSIS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
FIGURE 7 URINALYSIS MARKET, BY TEST TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 8 URINALYSIS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 9 URINALYSIS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 10 URINALYSIS MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
FIGURE 11 RISING GLOBAL INCIDENCE OF UTIS AND KIDNEY DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 12 CONSUMABLES DOMINATED THE NORTH AMERICAN URINALYSIS MARKET IN 2019
FIGURE 13 COUNTRIES IN ASIA TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 14 URINALYSIS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 GROWING AGING POPULATION, BY REGION, 2015 VS. 2030
FIGURE 16 CONSUMABLES SEGMENT TO WITNESS HIGHER GROWTH DURING THE FORECAST PERIOD
FIGURE 17 PREGNANCY & FERTILITY TESTS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2018
FIGURE 18 DISEASE SCREENING APPLICATIONS TO DOMINATE THE URINALYSIS MARKET DURING THE FORECAST PERIOD
FIGURE 19 HOSPITALS & CLINICS TO DOMINATE THE URINALYSIS MARKET DURING THE FORECAST PERIOD
FIGURE 20 APAC TO WITNESS THE HIGHEST GROWTH IN THE URINALYSIS MARKET DURING THE FORECAST PERIOD
FIGURE 21 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
FIGURE 22 POPULATION GROWTH IN THE US, 2016–2060
FIGURE 23 APAC: URINALYSIS MARKET SNAPSHOT
FIGURE 24 KEY DEVELOPMENTS IN THE URINALYSIS MARKET FROM 2016 TO 2019
FIGURE 25 BIOCHEMICAL URINALYSIS
FIGURE 26 SEDIMENT URINALYSIS
FIGURE 27 PREGNANCY AND FERTILITY TESTS
FIGURE 28 MNM DIVE-VENDOR COMPARISON MATRIX: URINALYSIS MARKET
FIGURE 29 MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: URINALYSIS MARKET
FIGURE 30 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
FIGURE 31 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
FIGURE 32 SIEMENS AG: COMPANY SNAPSHOT
FIGURE 33 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 35 SYSMEX CORPORATION: COMPANY SNAPSHOT
FIGURE 36 QUIDEL CORPORATION: COMPANY SNAPSHOT
FIGURE 37 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT

The global urinalysis market is expected to reach $1.28 billion by 2019 from $0.89 billion in 2014, growing at a CAGR of 7.6% from 2014 to 2019.

Key players in the urinalysis market include Alere Inc. (Acon Labs) (U.S.), ARKRAY Inc. (Japan), Bio-Rad (U.S.), Danaher (Iris International) (U.S.), E77 Eletronika (Hungary), Mindray (China), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Sysmex (Japan), and Urit Medical (China) amongst others

The report segments this market on the basis of products, test type, applications, end user, and geography. In the test type market, the biochemical urinalysis segment is expected to account for the largest share in 2014. The biochemical urinalysis is a cost effective and accurate method for diagnosing various types of diseases; this is a major reason for the high growth of this market. The sediment urinalysis segment is expected to grow at the highest CAGR from 2014 to 2019, due to the technological advancements and launch of new and advanced products in the market.

Based on geography, the global urinalysis market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2014. The growth of this market is driven by factors such as increasing number of prognostic urinalysis tests, implementation of affordable care act in the U.S., and rising incidences of diabetes in the region.

The material was prepared in April, 2015.

LIST OF TABLES

TABLE 1 URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 2 URINALYSIS CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 3 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 5 URINALYSIS DIPSTICKS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 6 URINALYSIS DISPOSABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 URINALYSIS REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 8 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 10 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 11 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 AUTOMATED SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 14 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 AUTOMATED MICROSCOPY ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 16 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 21 PREGNANCY & FERTILITY TESTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 23 BIOCHEMICAL URINALYSIS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 25 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 26 SEDIMENT URINALYSIS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 27 URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 28 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2017–2024 (USD MILLION)
TABLE 29 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2017–2024 (USD MILLION)
TABLE 30 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 31 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2017–2024 (USD MILLION)
TABLE 32 URINALYSIS MARKET FOR DIABETES, BY REGION, 2016–2023 (USD MILLION)
TABLE 33 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2017–2024 (USD MILLION)
TABLE 34 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 35 URINALYSIS MARKET FOR PREGNANCY & FERTILITY, BY REGION, 2017–2024 (USD MILLION)
TABLE 36 URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 37 URINALYSIS END-USER MARKET, BY PRODUCT, 2018 (USD MILLION)
TABLE 38 URINALYSIS END-USER MARKET, BY APPLICATION, 2018 (USD MILLION)
TABLE 39 URINALYSIS END-USER MARKET, BY TEST TYPE, 2018 (USD MILLION)
TABLE 40 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017–2024 (USD MILLION)
TABLE 41 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 42 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2017–2024 (USD MILLION)
TABLE 43 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2017–2024 (USD MILLION)
TABLE 44 URINALYSIS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 45 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 47 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 48 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 49 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 50 NORTH AMERICA: URINALYSIS END-USER MARKET, BY PRODUCT, 2018 (USD MILLION)
TABLE 51 NORTH AMERICA: URINALYSIS END-USER MARKET, BY APPLICATION, 2018 (USD MILLION)
TABLE 52 US: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 53 US: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 54 US: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 55 US: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 56 CANADA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 57 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 58 CANADA: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 59 CANADA: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 60 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 61 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 62 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 63 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 64 EUROPE: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65 EUROPE: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
TABLE 66 EUROPE: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
TABLE 67 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 68 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 69 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 70 GERMANY: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 71 UK: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 72 UK: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 73 UK: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 74 UK: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 75 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 76 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 77 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 78 FRANCE: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 79 ITALY: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 80 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 81 ITALY: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 82 ITALY: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 83 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 84 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 85 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 86 SPAIN: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 87 ROE: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 88 ROE: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 89 ROE: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 90 ROE: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 91 APAC: URINALYSIS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 92 APAC: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 93 APAC: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 94 APAC: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 95 APAC: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 96 APAC: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
TABLE 97 APAC: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
TABLE 98 CHINA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 99 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 100 CHINA: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 101 CHINA: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 102 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 103 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 104 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 105 JAPAN: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 106 INDIA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 107 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 108 INDIA: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 109 INDIA: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 110 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 111 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 112 ROAPAC: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 113 ROAPAC: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 114 ROW: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 115 ROW: URINALYSIS MARKET, BY TEST TYPE, 2017–2024 (USD MILLION)
TABLE 116 ROW: URINALYSIS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 117 ROW: URINALYSIS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 118 ROW: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
TABLE 119 ROW: URINALYSIS END USER MARKET BY APPLICATION, 2018 (USD MILLION)

Skip to top


Ask Your Question

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: